Skip to main content
. 2019 Oct 23;9:15224. doi: 10.1038/s41598-019-51665-0

Figure 3.

Figure 3

PA200 does not protect from bleomycin-induced lung fibrosis in mice. Lungs of PA200−/− and wildtype (WT) mice instilled with 2 U/kg body weight bleomycin (Bleo) or PBS as control were analyzed for the development of fibrosis at day 14. (a) Lung function analysis including resistance and compliance of wildtype (WT) and PA200−/− (KO) mice at day 14 after bleomycin (Bleo) or PBS instillation (Kruskal-Wallis test and Dunn’s multiple comparisons test, n = 11–16 per group). (b) Lungs of wildtype (WT) and PA200−/− (KO) mice 14 days after PBS- or bleomycin-instillation were analyzed for fibrotic marker collagen1α1 (Col1a1), fibronectin (Fn) and tenascin C (Tnc) mRNA expression by RTqPCR. Rpl19 served as housekeeping gene (Kruskal-Wallis test and Dunn’s multiple comparisons test, n = 12–17 per group; combined results from two independent animal experiments). (c) Representative hematoxylin & eosin staining of paraffin-embedded lung tissue sections at day 14 after bleomycin instillation.